Seeking Alpha

ANI Pharmaceuticals rallies after Teva deal

  • Shares of ANI Pharmaceuticals (ANIP) trade 11% higher in premarket action.
  • Investors appear pleased with the company's acquisition of 31 generic products from Teva.
  • The deal "demonstrates ANI's commitment to diversify [the] marketed product portfolio and supplement internal product development efforts," the company says.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)